Effectiveness and safety of ustekinumab in bio-naïve Crohn’s disease patients: a multicentre observational retrospective study

BACKGROUND: Clinical trials have demonstrated the efficacy and safety of ustekinumab in Crohn’s disease (CD). However, more data are necessary on the effectiveness of ustekinumab in bio-naïve patients in real-life studies. OBJECTIVES: The aim of our study was to evaluate the effectiveness and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Teresa, Valdés Delgado, Rául, Olmedo Martín, Marisa, Iborra, Claudia, Herrera de Guisé, Esteban, Fuentes-Valenzuela, Luigi, Melcarne, Mª Mar, Martín-Rodríguez, Lilyan, Kolle Casso, Luisa, De Castro Parga, Ángel, Ponferrada Díaz, Raquel, Vicente Lidón, Noemí, Manceñido Marcos, Benito, Velayos Jiménez, Marta, Lázaro Sáez, Beatriz, López Cauce, Francisco, Mesonero Gismero, Pau, Gilabert Álvarez, Federico, Argüelles-Arias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912551/
https://www.ncbi.nlm.nih.gov/pubmed/36777363
http://dx.doi.org/10.1177/17562848231153560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912551/
https://www.ncbi.nlm.nih.gov/pubmed/36777363
http://dx.doi.org/10.1177/17562848231153560

Ejemplares similares